Literature DB >> 18520227

Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer.

Hiromichi Ito1, Chandrakanth Are, Mithat Gonen, Michael D'Angelica, Ronald P Dematteo, Nancy E Kemeny, Yuman Fong, Leslie H Blumgart, William R Jarnagin.   

Abstract

PURPOSE: Resection is the most effective treatment for metastatic colorectal cancer (MCRC) to the liver. However, postoperative morbidity is common and its impact on long-term oncological outcome is unclear. The objective of this study was to evaluate the impact of postoperative morbidity on the long-term outcome after liver resection for MCRC.
METHODS: Medical records of patients who underwent liver resection for MCRC with curative intent between 1991 and 2002 were reviewed. Patients who died of postoperative complications were excluded; operative and perioperative data, including morbidity and clinicopathological variables, were analyzed. Patients were stratified by disease extent and risk of recurrence using a clinical risk scoring system.
RESULTS: A total of 1067 patients were included in the study and the median follow-up period was 41 months. The overall morbidity rate was 42%; the 5-year disease-specific survival (DSS) and overall disease-free survival (DFS) rates of patients who had complications were 41% and 25%, respectively, compared with 48% and 33%, respectively, for patients who did not have complications (P = 0.0059 for DSS, P = 0.0053 for DFS). On multivariate analysis, morbidity was not an independent predictor of either DSS or DFS; however, in a subgroup of patients with low clinical risk scores, morbidity was associated with a significant reduction in both DSS and DFS.
CONCLUSIONS: Postoperative morbidity adversely affects long-term outcome after hepatic resection for MCRC in patients at lower risk for recurrence. Efforts aimed at reducing perioperative morbidity will not only reduce usage of resources but will likely further enhance the therapeutic benefit of resection for such patients.

Entities:  

Mesh:

Year:  2008        PMID: 18520227     DOI: 10.1097/SLA.0b013e31816c405f

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  58 in total

1.  CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy.

Authors:  Constantinos T Sofocleous; Elena N Petre; Mithat Gonen; Karen T Brown; Stephen B Solomon; Anne M Covey; William Alago; Lynn A Brody; Raymond H Thornton; Michael D'Angelica; Yuman Fong; Nancy E Kemeny
Journal:  J Vasc Interv Radiol       Date:  2011-04-22       Impact factor: 3.464

2.  Complications following liver resection for colorectal metastases do not impact on longterm outcome.

Authors:  Tony C Pang; Calista Spiro; Tim Ramacciotti; Julian Choi; Martin Drummond; Edmund Sweeney; Jaswinder S Samra; Thomas J Hugh
Journal:  HPB (Oxford)       Date:  2014-08-26       Impact factor: 3.647

3.  Response to preoperative chemotherapy predicts survival in patients undergoing hepatectomy for liver metastases from gastric and esophageal cancer.

Authors:  Andreas Andreou; Luca Viganò; Giuseppe Zimmitti; Daniel Seehofer; Martin Dreyer; Andreas Pascher; Marcus Bahra; Wenzel Schoening; Volker Schmitz; Peter C Thuss-Patience; Timm Denecke; Gero Puhl; Jean-Nicolas Vauthey; Peter Neuhaus; Lorenzo Capussotti; Johann Pratschke; Sven-Christian Schmidt
Journal:  J Gastrointest Surg       Date:  2014-08-27       Impact factor: 3.452

Review 4.  Treatment Options in Colorectal Liver Metastases: Hepatic Arterial Infusion.

Authors:  Alice Zervoudakis; Taryn Boucher; Nancy E Kemeny
Journal:  Visc Med       Date:  2017-02-03

Review 5.  Thermal Ablation in the Management of Colorectal Cancer Patients with Oligometastatic Liver Disease.

Authors:  Elena Nadia Petre; Constantinos Sofocleous
Journal:  Visc Med       Date:  2017-02-03

6.  Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.

Authors:  Georgios Antonios Margonis; Stefan Buettner; Nikolaos Andreatos; Yuhree Kim; Doris Wagner; Kazunari Sasaki; Andrea Beer; Christoph Schwarz; Inger Marie Løes; Maria Smolle; Carsten Kamphues; Jin He; Timothy M Pawlik; Klaus Kaczirek; George Poultsides; Per Eystein Lønning; John L Cameron; Richard A Burkhart; Armin Gerger; Federico N Aucejo; Martin E Kreis; Christopher L Wolfgang; Matthew J Weiss
Journal:  JAMA Surg       Date:  2018-07-18       Impact factor: 14.766

7.  Surgical quality: more than just margins and lymph nodes.

Authors:  Aaron R Sasson; Quan P Ly; Chandrakanth Are
Journal:  Gastrointest Cancer Res       Date:  2009-09

8.  Predictive factors for bile leakage after hepatectomy: analysis of 505 consecutive patients.

Authors:  Ryuji Yoshioka; Akio Saiura; Rintaro Koga; Makoto Seki; Yoji Kishi; Junji Yamamoto
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

9.  How do we predict the clinically relevant pancreatic fistula after pancreaticoduodenectomy?--an analysis in 244 consecutive patients.

Authors:  Manabu Kawai; Masaji Tani; Seiko Hirono; Shinomi Ina; Motoki Miyazawa; Hiroki Yamaue
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

10.  Management of potentially resectable colorectal cancer liver metastases.

Authors:  Fausto Meriggi; Paola Bertocchi; Alberto Zaniboni
Journal:  World J Gastrointest Surg       Date:  2013-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.